188 related articles for article (PubMed ID: 34583200)
1. Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome.
Ringel C; Dittrich J; Gaudl A; Schellong P; Beuchel CF; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Büttner P; Löffler M; Scholz M; Thiery J; Ceglarek U
Atherosclerosis; 2021 Oct; 335():62-67. PubMed ID: 34583200
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
3. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction.
Bin Waleed K; Lu Y; Liu Q; Zeng F; Tu H; Wei Y; Xu S; Zhang Z; Rongfeng Y; Fan A; Altaf A; Chang J; Wang L
Medicine (Baltimore); 2020 Jul; 99(27):e20794. PubMed ID: 32629663
[TBL] [Abstract][Full Text] [Related]
4. Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
Tan Y; Sheng Z; Zhou P; Liu C; Zhao H; Song L; Li J; Zhou J; Chen Y; Wang L; Qian H; Sun Z; Qiao S; Xu B; Gao R; Yan H
Circ Cardiovasc Interv; 2019 Jan; 12(1):e007281. PubMed ID: 30599768
[TBL] [Abstract][Full Text] [Related]
5. Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases.
Spasova N; Somleva D; Krastev B; Ilieva R; Borizanova A; Svinarov D; Kinova E; Goudev A
Biosci Rep; 2024 Apr; 44(5):. PubMed ID: 38669041
[TBL] [Abstract][Full Text] [Related]
6. Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study.
Waleed KB; Tse G; Lu YK; Peng CN; Tu H; Ding LG; Xia YL; Wu SL; Li XT; Zhou HQ; Chen QY; Sun AM; Altaf A; Chang JL; Wang LL
Rev Cardiovasc Med; 2021 Mar; 22(1):231-238. PubMed ID: 33792267
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
8. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
10. Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome.
Kong W; Ma J; Lin Y; Chen W
Cardiovasc Ther; 2022; 2022():2484018. PubMed ID: 36420057
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
12. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
Sheng Z; Tan Y; Liu C; Zhou P; Li J; Zhou J; Chen R; Chen Y; Song L; Zhao H; Yan H
Am J Cardiol; 2019 Mar; 123(6):894-898. PubMed ID: 30594289
[TBL] [Abstract][Full Text] [Related]
13. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
[TBL] [Abstract][Full Text] [Related]
14. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
[TBL] [Abstract][Full Text] [Related]
15. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
Winther SA; Øllgaard JC; Hansen TW; von Scholten BJ; Reinhard H; Ahluwalia TS; Wang Z; Gæde P; Parving HH; Hazen S; Pedersen O; Rossing P
PLoS One; 2021; 16(3):e0244402. PubMed ID: 33657115
[TBL] [Abstract][Full Text] [Related]
16. Association Between Plasma Trimethylamine N-oxide and Neoatherosclerosis in Patients With Very Late Stent Thrombosis.
Tan Y; Zhou J; Liu C; Zhou P; Sheng Z; Li J; Chen R; Song L; Zhao H; Xu B; Gao R; Yan H
Can J Cardiol; 2020 Aug; 36(8):1252-1260. PubMed ID: 32595007
[TBL] [Abstract][Full Text] [Related]
17. Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease.
Bjørnestad EØ; Olset H; Dhar I; Løland K; Pedersen EKR; Svingen GFT; Svardal A; Berge RK; Ueland PM; Tell GS; Nilsen DWT; Nordrehaug JE; Nygaard E; Nygård O
J Intern Med; 2020 Oct; 288(4):446-456. PubMed ID: 32270523
[TBL] [Abstract][Full Text] [Related]
18. Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study.
Tripolt NJ; Leber B; Triebl A; Köfeler H; Stadlbauer V; Sourij H
Atherosclerosis; 2015 Sep; 242(1):141-4. PubMed ID: 26188537
[TBL] [Abstract][Full Text] [Related]
19. The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy.
Xiong X; Zhou J; Fu Q; Xu X; Wei S; Yang S; Chen B
Lipids Health Dis; 2022 Jul; 21(1):60. PubMed ID: 35864500
[TBL] [Abstract][Full Text] [Related]
20. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.
Senthong V; Li XS; Hudec T; Coughlin J; Wu Y; Levison B; Wang Z; Hazen SL; Tang WH
J Am Coll Cardiol; 2016 Jun; 67(22):2620-8. PubMed ID: 27256833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
